AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity
Top Cited Papers
- 6 January 2011
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 19 (1), 58-71
- https://doi.org/10.1016/j.ccr.2010.10.031
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Resiliency and Vulnerability in the HER2-HER3 Tumorigenic DriverScience Translational Medicine, 2010
- Inhibitor hijacking of Akt activationNature Chemical Biology, 2009
- V600E BRAF is associated with disabled feedback inhibition of RAF–MEK signaling and elevated transcriptional output of the pathwayProceedings of the National Academy of Sciences, 2009
- System-wide Investigation of ErbB4 Reveals 19 Sites of Tyr Phosphorylation that Are Unusually Selective in Their Recruitment PropertiesChemistry & Biology, 2008
- Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3Nature, 2007
- A negative feedback signaling network underlies oncogene-induced senescenceCancer Cell, 2006
- BRAF mutation predicts sensitivity to MEK inhibitionNature, 2005
- Transcriptional feedback control of insulin receptor by dFOXO/FOXO1Genes & Development, 2005
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005
- A C. elegans mutant that lives twice as long as wild typeNature, 1993